These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18514201)

  • 1. Implantation of paclitaxel-eluting stent impairs the vascular compliance of arteries in porcine coronary stenting model.
    Farhan S; Hemetsberger R; Matiasek J; Strehblow C; Pavo N; Khorsand A; Petneházy O; Petrási Z; Kaider A; Glogar D; Huber K; Gyöngyösi M
    Atherosclerosis; 2009 Jan; 202(1):144-51. PubMed ID: 18514201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-dependent vasomotor dysfunction in pig coronary arteries with Paclitaxel-eluting stents is associated with inflammation and oxidative stress.
    Pendyala LK; Li J; Shinke T; Geva S; Yin X; Chen JP; King SB; Robinson KA; Chronos NA; Hou D
    JACC Cardiovasc Interv; 2009 Mar; 2(3):253-62. PubMed ID: 19463433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular responses to drug-eluting and bare metal stents in diabetic/hypercholesterolemic and nonatherosclerotic porcine coronary arteries.
    Llano R; Winsor-Hines D; Patel DB; Seifert PS; Hamamdzic D; Wilson GJ; Wang H; Keane MG; Huibregtse BA; Wilensky RL
    Circ Cardiovasc Interv; 2011 Oct; 4(5):438-46. PubMed ID: 21972400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
    Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of intramural thrombus after overlapping paclitaxel-eluting stent implantation: angioscopic and histopathologic analysis in porcine coronary arteries.
    Shinke T; Li J; Chen JP; Pendyala L; Goodchild T; Jabara R; Geva S; Ueno T; Chronos N; Robinson K; Hou D
    Circ Cardiovasc Interv; 2008 Aug; 1(1):28-35. PubMed ID: 20031652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent.
    Kim JW; Suh SY; Choi CU; Na JO; Kim EJ; Rha SW; Park CG; Seo HS; Oh DJ
    JACC Cardiovasc Interv; 2008 Feb; 1(1):65-71. PubMed ID: 19393147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis.
    Erglis A; Narbute I; Kumsars I; Jegere S; Mintale I; Zakke I; Strazdins U; Saltups A
    J Am Coll Cardiol; 2007 Aug; 50(6):491-7. PubMed ID: 17678730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
    Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK
    J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific coronary drug-eluting stents interfere with distal microvascular function after single stent implantation in pigs.
    van den Heuvel M; Sorop O; Batenburg WW; Bakker CL; de Vries R; Koopmans SJ; van Beusekom HM; Duncker DJ; Danser AH; van der Giessen WJ
    JACC Cardiovasc Interv; 2010 Jul; 3(7):723-30. PubMed ID: 20650434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
    Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
    Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury.
    Buszman PP; Tellez A; Afari M; Cheng Y; Conditt GB; McGregor JC; Milewski K; Stenoien M; Kaluza GL; Granada JF
    EuroIntervention; 2013 Aug; 9(4):510-6. PubMed ID: 23965356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms.
    Buszman PP; Milewski K; Pająk J; Jelonek M; Orlik B; Krauze A; Gwiazdowska-Nowotka B; Wojakowski W; Tellez A; Granada JF; Buszman PE
    EuroIntervention; 2014 Oct; 10(6):724-31. PubMed ID: 24469344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose paclitaxel elution by novel bioerodible sol-gel coating on stents inhibits neointima with low toxicity in porcine coronary arteries.
    Shinke T; Geva S; Pendyala L; Jabara R; Li J; Chen JP; Venegoni A; Colley K; Klein R; Chronos N; Robinson K; Hou D
    Int J Cardiol; 2009 Jun; 135(1):93-101. PubMed ID: 18692915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early vascular response to overlapped paclitaxel-eluting stents in swine coronary arteries.
    Seifert PS; Huibregtse BA; Polovick J; Poff B
    Cardiovasc Revasc Med; 2007; 8(4):251-8. PubMed ID: 18053947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-stent coronary restenosis, but not the type of stent, is associated with impaired endothelial-dependent vasodilatation.
    Mizia-Stec K; Gasior Z; Haberka M; Mizia M; Chmiel A; Janowska J; Holecki M; Mielczarek M; Zahorska-Markiewicz B
    Kardiol Pol; 2009 Jan; 67(1):9-17; discussion 18. PubMed ID: 19253185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents.
    Nakazawa G; Finn AV; John MC; Kolodgie FD; Virmani R
    Am J Cardiol; 2007 Oct; 100(8B):36M-44M. PubMed ID: 17950831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus-eluting stents compared with paclitaxel-eluting stents for treatment of coronary in-stent restenoses.
    Markovic S; Paliskyte R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2012; 13(6):307-10. PubMed ID: 23164475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimusand tacrolimus-eluting stents.
    van Beusekom HM; Sorop O; van den Heuvel M; Onuma Y; Duncker DJ; Danser AH; van der Giessen WJ
    EuroIntervention; 2010 May; 6(1):117-25. PubMed ID: 20542807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent).
    Ellis SG; Stone GW; Cox DA; Hermiller J; O'Shaughnessy C; Mann T; Turco M; Caputo R; Bergin PJ; Bowman TS; Baim DS;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1248-59. PubMed ID: 20129552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis.
    Lim SY; Jeong MH; Hong SJ; Lim DS; Moon JY; Hong YJ; Kim JH; Ahn Y; Kang JC
    Circ J; 2008 Mar; 72(3):463-8. PubMed ID: 18296847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.